Skip to main content
Fig. 2 | Journal of Cardiothoracic Surgery

Fig. 2

From: Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery – a retrospective analysis

Fig. 2

Kaplan-Meier estimation for long-term survival. Vertical lines at one, two and three years postoperatively. a. Overall survival. After an initial decline, survival remains stable after one two and three years in both groups. Survival curves do not differ. b. After isolated CABG, patients who received LS showed lower survival without statistical significance. c. After isolated valve or aortic surgery, LS patients show stable survival compared to reduced survival in the control group without statistical significance. D. After combination procedures, survival curves between the groups do not differ. Abbreviations: CABG: Coronary artery bypass grafting surgery, LS: Levosimendan

Back to article page

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us